Strategy

PART 2 - Why Global Pharma Is Betting Big on Chinese Biotech Innovation | Ep. 556

Innovation Trends & Winning Strategies for MNCs

Jan 19 •

PART 1 - China R&D Heats Up | Ep. 549

Innovative vs. Fast Follower vs. Me Too

Jan 12 •

European Biotech Valuation Trends | Ep. 541

Activity, Valuations, Exits

Jan 5 •

Epoch 52: 10 Biotech Buyout Predictions for 2025

MDGL VKTX ITCI AXSM LEGN ARWR XENE IDYA PLRX

Dec 29, 2024 •

Epoch 51: 25 Biotech Predictions for 2025

The Best is Yet to Come!

Dec 22, 2024 •

Epoch 50: Top 10 Biotech Themes from 2024

A Year in Review

Dec 15, 2024 •

Epoch 49: Cheat Sheet to Biotech Impacts of Trump’s Healthcare Appointees

HHS, FDA, CMS, NIH

Dec 8, 2024 •

Epoch 48: Why Biotechs Are Buying Bitcoin

The Strategic Case for BTC in Corporate Treasuries

Dec 1, 2024 •

Epoch 47: Vivek & Balaji Talk Biotech

MDMA & Psychedelics, FDA Reform, Alt. Regulatory Paths, A New Role for Biotech

Nov 24, 2024 •

Epoch 46: The Biotech Investor’s Guide to Pre-Catalyst Timing

Optimizing Buy Timing, Market Caps, and Development Stages

Nov 17, 2024 •

Epoch 45: Family Offices & Biotech

Investment Strategies & Relationship with Venture Capital

Nov 10, 2024 •

Epoch 44: US vs EU Venture Capital

Which approach is more effecient?

Nov 3, 2024 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts